BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36836227)

  • 1. Methods for the Inclusion of Real-World Evidence in a Rare Events Meta-Analysis of Randomized Controlled Trials.
    Yao M; Wang Y; Mei F; Zou K; Li L; Sun X
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for the inclusion of real-world evidence in network meta-analysis.
    Jenkins DA; Hussein H; Martina R; Dequen-O'Byrne P; Abrams KR; Bujkiewicz S
    BMC Med Res Methodol; 2021 Oct; 21(1):207. PubMed ID: 34627166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of statistical methods for integrating real-world evidence in a rare events meta-analysis of randomized controlled trials.
    Yao M; Wang Y; Ren Y; Jia Y; Zou K; Li L; Sun X
    Res Synth Methods; 2023 Sep; 14(5):689-706. PubMed ID: 37309821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation.
    Wheaton L; Papanikos A; Thomas A; Bujkiewicz S
    Med Decis Making; 2023 Jul; 43(5):539-552. PubMed ID: 36998240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inclusion of real world evidence in clinical development planning.
    Martina R; Jenkins D; Bujkiewicz S; Dequen P; Abrams K;
    Trials; 2018 Aug; 19(1):468. PubMed ID: 30157904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.
    Briere JB; Bowrin K; Taieb V; Millier A; Toumi M; Coleman C
    Curr Med Res Opin; 2018 Dec; 34(12):2125-2130. PubMed ID: 30217138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.
    Franklin JM; Patorno E; Desai RJ; Glynn RJ; Martin D; Quinto K; Pawar A; Bessette LG; Lee H; Garry EM; Gautam N; Schneeweiss S
    Circulation; 2021 Mar; 143(10):1002-1013. PubMed ID: 33327727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analysis.
    Digkas E; Tabiim AJ; Smith D; Valachis A
    Target Oncol; 2022 Sep; 17(5):507-515. PubMed ID: 35913645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.
    Thieffry S; Klein P; Baulac M; Plumb J; Pelgrims B; Steeves S; Borghs S
    Epilepsia; 2020 Apr; 61(4):595-609. PubMed ID: 32201951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hierarchical network meta-analysis models for synthesis of evidence from randomised and non-randomised studies.
    Hussein H; Abrams KR; Gray LJ; Anwer S; Dias S; Bujkiewicz S
    BMC Med Res Methodol; 2023 Apr; 23(1):97. PubMed ID: 37087450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DESIGN DIFFERENCES EXPLAIN VARIATION IN RESULTS BETWEEN RANDOMIZED TRIALS AND THEIR NON-RANDOMIZED EMULATIONS.
    Heyard R; Held L; Schneeweiss S; Wang SV
    medRxiv; 2023 Jul; ():. PubMed ID: 37502999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
    Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional labelling for healthier food or non-alcoholic drink purchasing and consumption.
    Crockett RA; King SE; Marteau TM; Prevost AT; Bignardi G; Roberts NW; Stubbs B; Hollands GJ; Jebb SA
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD009315. PubMed ID: 29482264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of real-world evidence in meta-analyses and cost-effectiveness models.
    Bowrin K; Briere JB; Levy P; Toumi M; Millier A
    J Med Econ; 2020 Oct; 23(10):1053-1060. PubMed ID: 32657189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Attempt to Replicate Randomized Trials of Diabetes Treatments Using a Japanese Administrative Claims and Health Checkup Database: A Feasibility Study.
    Wakabayashi R; Hirano T; Koga T; Kuwatsuru R
    Drugs Real World Outcomes; 2023 Jun; 10(2):235-247. PubMed ID: 36725811
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.